应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ATAI ATAI Life Sciences B.V.*
休市中 08-30 16:00:00 EDT
1.30
+0.00
0.00%
盘后
1.30
+0.00
0.00%
19:59 EDT
最高
1.33
最低
1.29
成交量
39.49万
今开
1.29
昨收
1.30
日振幅
3.08%
总市值
2.18亿
流通市值
1.67亿
总股本
1.68亿
成交额
51.71万
换手率
0.31%
流通股本
1.29亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Atai Life Sciences N.V.盘中异动 急速拉升5.32%报1.38美元
自选股智能写手 · 08-20
Atai Life Sciences N.V.盘中异动 急速拉升5.32%报1.38美元
Atai Life Sciences N.V.盘中异动 股价大涨5.74%报1.29美元
自选股智能写手 · 08-20
Atai Life Sciences N.V.盘中异动 股价大涨5.74%报1.29美元
Atai Life Sciences N.V.2024财年第二财季实现净利润-57.31百万美元,同比减少73.46%
自选股智能写手 · 08-19
Atai Life Sciences N.V.2024财年第二财季实现净利润-57.31百万美元,同比减少73.46%
Atai Life Sciences N.V.盘中异动 早盘快速上涨5.12%报1.23美元
自选股智能写手 · 08-15
Atai Life Sciences N.V.盘中异动 早盘快速上涨5.12%报1.23美元
Atai Life Sciences N.V.盘中异动 快速跳水5.33%报1.16美元
自选股智能写手 · 08-14
Atai Life Sciences N.V.盘中异动 快速跳水5.33%报1.16美元
Atai Life Sciences N.V.盘中异动 早盘大幅下跌5.51%报1.20美元
自选股智能写手 · 08-12
Atai Life Sciences N.V.盘中异动 早盘大幅下跌5.51%报1.20美元
Atai Life Sciences N.V.盘中异动 下午盘股价大跌5.11%
自选股智能写手 · 08-08
Atai Life Sciences N.V.盘中异动 下午盘股价大跌5.11%
Atai Life Sciences N.V.盘中异动 股价大跌9.71%报1.26美元
自选股智能写手 · 08-05
Atai Life Sciences N.V.盘中异动 股价大跌9.71%报1.26美元
Atai Life Sciences N.V.盘中异动 临近午盘急速跳水5.16%报1.47美元
自选股智能写手 · 08-01
Atai Life Sciences N.V.盘中异动 临近午盘急速跳水5.16%报1.47美元
Atai Life Sciences N.V.盘中异动 下午盘股价大涨5.19%报1.60美元
自选股智能写手 · 08-01
Atai Life Sciences N.V.盘中异动 下午盘股价大涨5.19%报1.60美元
HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价由15.
智通财经 · 07-31
HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价由15.
Atai Life Sciences N.V.盘中异动 股价大跌5.06%报1.50美元
自选股智能写手 · 07-31
Atai Life Sciences N.V.盘中异动 股价大跌5.06%报1.50美元
Atai Life Sciences N.V.盘中异动 大幅上涨5.66%报1.68美元
自选股智能写手 · 07-29
Atai Life Sciences N.V.盘中异动 大幅上涨5.66%报1.68美元
Atai Life Sciences N.V.盘中异动 下午盘股价大涨5.63%报1.60美元
自选股智能写手 · 07-26
Atai Life Sciences N.V.盘中异动 下午盘股价大涨5.63%报1.60美元
Atai Life Sciences N.V.盘中异动 下午盘急速下跌5.10%报1.49美元
自选股智能写手 · 07-25
Atai Life Sciences N.V.盘中异动 下午盘急速下跌5.10%报1.49美元
Atai Life Sciences N.V.盘中异动 快速上涨5.37%报1.57美元
自选股智能写手 · 07-24
Atai Life Sciences N.V.盘中异动 快速上涨5.37%报1.57美元
成分股Vir Biotech收涨19.66%诺瓦瓦克斯医药(NVAX)涨18.07%Terns Pharmaceuticals、Protagonist Therapeutics、Pacific Biosciences of California、Adaptive、Biotechnologies涨16.
智通财经 · 06-06
成分股Vir Biotech收涨19.66%诺瓦瓦克斯医药(NVAX)涨18.07%Terns Pharmaceuticals、Protagonist Therapeutics、Pacific Biosciences of California、Adaptive、Biotechnologies涨16.
【FDA顾问小组拒绝MDMA营销授权 迷幻药概念股暴跌】智通财经APP获悉,美国食品药品监督管理局(FDA)的独立顾问小组对Lykos Therapeutics公司提交的用于治疗创伤后应激障碍(PTSD)的精神病治疗药物米诺地那非(MDMA,俗称摇头丸)的营销授权申请投了反对票,这一决定导致迷幻药主要开发商的股价在周三盘初交易中出现下跌,Mind Medicine (MNMD.
智通财经 · 06-05
【FDA顾问小组拒绝MDMA营销授权 迷幻药概念股暴跌】智通财经APP获悉,美国食品药品监督管理局(FDA)的独立顾问小组对Lykos Therapeutics公司提交的用于治疗创伤后应激障碍(PTSD)的精神病治疗药物米诺地那非(MDMA,俗称摇头丸)的营销授权申请投了反对票,这一决定导致迷幻药主要开发商的股价在周三盘初交易中出现下跌,Mind Medicine (MNMD.
HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价15.00美元。
智通财经 · 05-18
HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价15.00美元。
HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价15.
智通财经 · 05-18
HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价15.
暂无数据
公司概况
公司名称:
ATAI Life Sciences B.V.*
所属市场:
NASDAQ
上市日期:
--
主营业务:
ATAI Life Sciences N.V.于2020年9月10日根据荷兰法律注册为Adripa Holding B.V.。2021年1月11日,更名为ATAI Life Sciences B.V.。他们是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方法。
发行价格:
--
{"stockData":{"symbol":"ATAI","market":"US","secType":"STK","nameCN":"ATAI Life Sciences B.V.*","latestPrice":1.3,"timestamp":1725048000000,"preClose":1.3,"halted":0,"volume":394876,"hourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.3,"latestTime":"19:59 EDT","volume":220,"amount":293.4606,"timestamp":1725062397354},"delay":0,"floatShares":128627127,"shares":167798955,"eps":-0.36123,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"08-30 16:00:00 EDT","open":1.29,"high":1.33,"low":1.29,"amount":517071.36539,"amplitude":0.030769,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.36123,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1725350400000},"adr":1,"listingDate":1623988800000,"adjPreClose":1.3,"adrRate":2,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.3,"latestTime":"09:00 EDT","volume":99,"amount":127.2799935,"timestamp":1725022829772},"postHourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.3,"latestTime":"19:59 EDT","volume":220,"amount":293.4606,"timestamp":1725062397354},"volumeRatio":0.8516686978116257,"impliedVol":4.6593,"impliedVolPercentile":0.9603},"requestUrl":"/m/hq/s/ATAI/tweets","defaultTab":"tweets","newsList":[{"id":"2460444002","title":"Atai Life Sciences N.V.盘中异动 急速拉升5.32%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460444002","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460444002?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:59","pubTimestamp":1724162367,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时59分,Atai Life Sciences N.V.股票出现波动,股价急速拉升5.32%。截至发稿,该股报1.38美元/股,成交量16.1574万股,换手率0.10%,振幅5.73%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为0.31%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820215928a1d53c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820215928a1d53c62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ATAI"],"gpt_icon":0},{"id":"2460717051","title":"Atai Life Sciences N.V.盘中异动 股价大涨5.74%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717051","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717051?lang=zh_cn&edition=full","pubTime":"2024-08-20 00:41","pubTimestamp":1724085687,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日00时41分,Atai Life Sciences N.V.股票出现异动,股价急速上涨5.74%。截至发稿,该股报1.29美元/股,成交量43.4792万股,换手率0.26%,振幅3.69%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为1.33%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820004127971992de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820004127971992de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALZN","BK4139","ATAI","BK4539"],"gpt_icon":0},{"id":"2460891710","title":"Atai Life Sciences N.V.2024财年第二财季实现净利润-57.31百万美元,同比减少73.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460891710","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460891710?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:00","pubTimestamp":1723996854,"startTime":"0","endTime":"0","summary":"8月19日,Atai Life Sciences N.V.公布财报,公告显示公司2024财年第二财季净利润为-57.31百万美元,同比减少73.46%;其中营业收入为273000.00美元,同比增加58.72%,每股基本收益为-0.36美元。从资产负债表来看,Atai Life Sciences N.V.总负债47.25百万美元,其中短期债务239000.00美元,资产负债比为0.05,流动比率为0.07。机构评级:截至2024年8月19日,当前有5家机构对Atai Life Sciences N.V.目标价做出预测,其中目标均价为8.80美元,其中最低目标价为5.00美元,最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190001089f363b15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190001089f363b15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATAI"],"gpt_icon":0},{"id":"2459474836","title":"Atai Life Sciences N.V.盘中异动 早盘快速上涨5.12%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459474836","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459474836?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:07","pubTimestamp":1723734469,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时07分,Atai Life Sciences N.V.股票出现波动,股价急速上涨5.12%。截至发稿,该股报1.23美元/股,成交量22.2302万股,换手率0.13%,振幅3.85%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为0.69%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523074997198d75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523074997198d75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","ATAI"],"gpt_icon":0},{"id":"2459084401","title":"Atai Life Sciences N.V.盘中异动 快速跳水5.33%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459084401","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459084401?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:34","pubTimestamp":1723646081,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时34分,Atai Life Sciences N.V.股票出现异动,股价大幅下跌5.33%。截至发稿,该股报1.16美元/股,成交量32.2739万股,换手率0.19%,振幅4.92%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为0.03%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422344198e34f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422344198e34f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ATAI","BK4007"],"gpt_icon":0},{"id":"2458854399","title":"Atai Life Sciences N.V.盘中异动 早盘大幅下跌5.51%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458854399","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458854399?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469470,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分,Atai Life Sciences N.V.股票出现异动,股价急速下跌5.51%。截至发稿,该股报1.20美元/股,成交量15.5677万股,换手率0.09%,振幅4.72%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体跌幅为0.44%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213110aefe6ab5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213110aefe6ab5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ATAI","BK4007"],"gpt_icon":0},{"id":"2457822781","title":"Atai Life Sciences N.V.盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457822781","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457822781?lang=zh_cn&edition=full","pubTime":"2024-08-08 01:07","pubTimestamp":1723050449,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日01时07分,Atai Life Sciences N.V.股票出现异动,股价快速下跌5.11%。截至发稿,该股报1.30美元/股,成交量48.8789万股,换手率0.29%,振幅6.57%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体跌幅为2.23%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808010729941ff174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808010729941ff174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ATAI","BK4007"],"gpt_icon":0},{"id":"2457773727","title":"Atai Life Sciences N.V.盘中异动 股价大跌9.71%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457773727","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457773727?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:41","pubTimestamp":1722865290,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时41分,Atai Life Sciences N.V.股票出现波动,股价急速下挫9.71%。截至发稿,该股报1.26美元/股,成交量20.3512万股,换手率0.12%,振幅3.60%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体跌幅为2.33%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052141309f10754c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052141309f10754c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATAI","BK4539","BK4007"],"gpt_icon":0},{"id":"2456453453","title":"Atai Life Sciences N.V.盘中异动 临近午盘急速跳水5.16%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456453453","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456453453?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:53","pubTimestamp":1722527626,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时53分,Atai Life Sciences N.V.股票出现异动,股价快速跳水5.16%。截至发稿,该股报1.47美元/股,成交量29.7069万股,换手率0.18%,振幅4.84%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为0.67%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。消息层面,截至23时53分,《H.C. Wainwright维持ATAI Life Sciences买入评级,维持目标价15美元》资讯为影响Atai Life Sciences N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080123534796822c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080123534796822c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATAI","BK4007","BK4539","BK4139","IMRX","BK4563"],"gpt_icon":0},{"id":"2456693111","title":"Atai Life Sciences N.V.盘中异动 下午盘股价大涨5.19%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456693111","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456693111?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:46","pubTimestamp":1722451572,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日02时46分,Atai Life Sciences N.V.股票出现波动,股价大幅上涨5.19%。截至发稿,该股报1.60美元/股,成交量32.1631万股,换手率0.19%,振幅7.23%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为1.15%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。消息层面,截至02时46分,《H.C. Wainwright维持ATAI Life Sciences买入评级,维持目标价15美元》资讯为影响Atai Life Sciences N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801024613aefc7f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801024613aefc7f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ATAI"],"gpt_icon":0},{"id":"2455138922","title":"HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价由15.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455138922","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455138922?lang=zh_cn&edition=full","pubTime":"2024-07-31 20:29","pubTimestamp":1722428956,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4539","ATAI","BK4007"],"gpt_icon":0},{"id":"2455496094","title":"Atai Life Sciences N.V.盘中异动 股价大跌5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455496094","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455496094?lang=zh_cn&edition=full","pubTime":"2024-07-31 03:37","pubTimestamp":1722368238,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日03时37分,Atai Life Sciences N.V.股票出现异动,股价急速下挫5.06%。截至发稿,该股报1.50美元/股,成交量39.6653万股,换手率0.24%,振幅6.46%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为0.06%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731033719aefc37e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731033719aefc37e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ATAI","BK4007"],"gpt_icon":0},{"id":"2455665146","title":"Atai Life Sciences N.V.盘中异动 大幅上涨5.66%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455665146","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455665146?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:36","pubTimestamp":1722260198,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日21时36分,Atai Life Sciences N.V.股票出现波动,股价大幅拉升5.66%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Palisade Bio, Inc.较为活跃,换手率分别为1272.68%、146.64%、144.77%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为76.71%、51.05%、35.22%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213638aefbfa05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213638aefbfa05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATAI","BK4539","BK4007"],"gpt_icon":0},{"id":"2454802712","title":"Atai Life Sciences N.V.盘中异动 下午盘股价大涨5.63%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454802712","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454802712?lang=zh_cn&edition=full","pubTime":"2024-07-26 01:02","pubTimestamp":1721926967,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日01时02分,Atai Life Sciences N.V.股票出现异动,股价快速上涨5.63%。截至发稿,该股报1.60美元/股,成交量17.691万股,换手率0.11%,振幅5.96%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体跌幅为0.08%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010248aefb7b15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010248aefb7b15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATAI","BK4539","BK4007"],"gpt_icon":0},{"id":"2454834752","title":"Atai Life Sciences N.V.盘中异动 下午盘急速下跌5.10%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454834752","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454834752?lang=zh_cn&edition=full","pubTime":"2024-07-25 02:54","pubTimestamp":1721847294,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日02时54分,Atai Life Sciences N.V.股票出现波动,股价急速跳水5.10%。截至发稿,该股报1.49美元/股,成交量29.0957万股,换手率0.17%,振幅6.69%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为0.07%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725025455af93ec1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725025455af93ec1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","ATAI"],"gpt_icon":1},{"id":"2453523940","title":"Atai Life Sciences N.V.盘中异动 快速上涨5.37%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453523940","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453523940?lang=zh_cn&edition=full","pubTime":"2024-07-24 00:03","pubTimestamp":1721750609,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日00时03分,Atai Life Sciences N.V.股票出现异动,股价大幅拉升5.37%。Atai Life Sciences N.V.股票所在的生物技术行业中,整体涨幅为1.08%。其相关个股中,Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大,Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃,换手率分别为7313.95%、5522.44%、3455.47%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc,振幅分别为366.13%、365.43%、137.74%。Atai Life Sciences N.V.公司简介:ATAI Life Sciences NV 是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724000329af93ae0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724000329af93ae0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATAI","BK4539","BK4007"],"gpt_icon":0},{"id":"2441164786","title":"成分股Vir Biotech收涨19.66%诺瓦瓦克斯医药(NVAX)涨18.07%Terns Pharmaceuticals、Protagonist Therapeutics、Pacific Biosciences of California、Adaptive、Biotechnologies涨16.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441164786","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441164786?lang=zh_cn&edition=full","pubTime":"2024-06-06 05:05","pubTimestamp":1717621513,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4121","BK4120","BK4539","BK4585","LENZ","BK4547","BK4139","BK4568","NVAX","TERN","BV","BK4007","ATAI","PACB","BK4588"],"gpt_icon":0},{"id":"2441412279","title":"【FDA顾问小组拒绝MDMA营销授权 迷幻药概念股暴跌】智通财经APP获悉,美国食品药品监督管理局(FDA)的独立顾问小组对Lykos Therapeutics公司提交的用于治疗创伤后应激障碍(PTSD)的精神病治疗药物米诺地那非(MDMA,俗称摇头丸)的营销授权申请投了反对票,这一决定导致迷幻药主要开发商的股价在周三盘初交易中出现下跌,Mind Medicine (MNMD.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441412279","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441412279?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:36","pubTimestamp":1717594587,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNMD","BK4547","BK4539","LENZ","CMPS","BK4139","BK4007","ATAI","CYBN","BK4168"],"gpt_icon":0},{"id":"2436941313","title":"HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2436941313","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436941313?lang=zh_cn&edition=full","pubTime":"2024-05-18 01:25","pubTimestamp":1715966716,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180125198b133bd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180125198b133bd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATAI"],"gpt_icon":0},{"id":"2436949732","title":"HC Wainwright & Co.:重申ATAI Life Sciences(ATAI.US)评级,由买入调整至买入评级, 目标价15.","url":"https://stock-news.laohu8.com/highlight/detail?id=2436949732","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436949732?lang=zh_cn&edition=full","pubTime":"2024-05-18 01:15","pubTimestamp":1715966137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ATAI","BK4539","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atai.life","stockEarnings":[{"period":"1week","weight":-0.0076},{"period":"1month","weight":-0.1613},{"period":"3month","weight":-0.172},{"period":"6month","weight":-0.3897},{"period":"1year","weight":-0.1503},{"period":"ytd","weight":-0.078}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0689},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2516},{"period":"ytd","weight":0.1859}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ATAI Life Sciences N.V.于2020年9月10日根据荷兰法律注册为Adripa Holding B.V.。2021年1月11日,更名为ATAI Life Sciences B.V.。他们是一家临床阶段的生物制药公司,旨在改变精神疾病的治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.123286},{"month":2,"riseRate":0.666667,"avgChangeRate":0.036877},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.006798},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.032282},{"month":5,"riseRate":0,"avgChangeRate":-0.114053},{"month":6,"riseRate":0,"avgChangeRate":-0.092466},{"month":7,"riseRate":0.75,"avgChangeRate":0.069702},{"month":8,"riseRate":0.5,"avgChangeRate":-0.051664},{"month":9,"riseRate":0,"avgChangeRate":-0.172792},{"month":10,"riseRate":0,"avgChangeRate":-0.056265},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.068431},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.065263}],"exchange":"NASDAQ","name":"ATAI Life Sciences B.V.*","nameEN":"ATAI Life Sciences B.V.*"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ATAI Life Sciences B.V.*(ATAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ATAI Life Sciences B.V.*(ATAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ATAI Life Sciences B.V.*,ATAI,ATAI Life Sciences B.V.*股票,ATAI Life Sciences B.V.*股票老虎,ATAI Life Sciences B.V.*股票老虎国际,ATAI Life Sciences B.V.*行情,ATAI Life Sciences B.V.*股票行情,ATAI Life Sciences B.V.*股价,ATAI Life Sciences B.V.*股市,ATAI Life Sciences B.V.*股票价格,ATAI Life Sciences B.V.*股票交易,ATAI Life Sciences B.V.*股票购买,ATAI Life Sciences B.V.*股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ATAI Life Sciences B.V.*(ATAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ATAI Life Sciences B.V.*(ATAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}